Oragenics

Yahoo Finance • last month

Oragenics Receives HREC Approval for Phase IIa Clinical Trial of ONP-002 as a Treatment for Concussion and Mild Traumatic Brain Injury in Australia

All required regulatory approvals secured for trial site onboarding and patient enrollment at three Australian sites Potential first and only pharmacological treatment for the most prominent neurological condition without an FDA-approved... Full story

Yahoo Finance • 6 months ago

Oragenics announces partnership with Receptor.AI

* Oragenics (NYSE:OGEN [https://seekingalpha.com/symbol/OGEN]) on Tuesday said that it has collaboreted with Receptor.AI, an artificial intelligence-driven drug profiling company, to accelerate the development of its neurological drug pi... Full story

Yahoo Finance • 8 months ago

Oragenics Q2 2025 Shareholder Update

Advancing Brain-First Recovery Platform Toward Clinical Milestones Pioneering Intranasal Therapeutics for Concussion SARASOTA, Fla., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a pioneering biotechnology co... Full story

Yahoo Finance • 9 months ago

Oragenics announces $20M preferred stock offering; shares surge over 138%

* Oragenics (NYSE:OGEN [https://seekingalpha.com/symbol/OGEN]) entered a placement agreement to sell up to 800,000 shares of Series H convertible preferred stock and accompanying warrants. * Each unit, consisting of one preferred stock... Full story

Yahoo Finance • 4 years ago

Here's why meme stocks are hinting at another flashy rally for `junk stocks`

Meme stocks are perking up again, with GameStop (GME) and AMC Entertainment (AMC) rallying over 30% at one point on Thursday, and adding 10% and 5%, respectively, on Friday. Separately, the ARK Innovation ETF (ARKK) shot up 25% off Thursda... Full story